Skip to contentSkip to filters

We use cookies for analytics.

Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study

David R. Walt, Zoe Newell Swank and Elizabeth W. Karlson

Harvard Medical School; Brigham and Women's Hospital; Wyss Institute at Harvard University

Recording

1 h 26 min

Abstract

Viral persistence, in which SARS-CoV-2 remains in the body and continues to cause changes after the initial illness, is a candidate explanation for some Long COVID symptoms. David Walt reviews what is known about viral persistence and how it can be measured by detecting viral antigens in blood. Zoe Swank describes the participating cohorts, including several from outside RECOVER, and an ultrasensitive assay able to detect antigen levels too low for older methods. Elizabeth Karlson reports that people with Long COVID were twice as likely as those without symptoms to have circulating antigens, although some people without symptoms carried them too, and that specific symptom clusters were strongly associated with antigen presence: 43 percent of antigen-positive participants reported symptoms affecting the heart, lungs, brain, joints and muscles. Walt closes with open questions about viral persistence for diagnosis and treatment and with the RECOVER-VITAL trial of antivirals for Long COVID. Discussion covers links to ME/CFS, the organs and cells where the virus may persist, differences between variants, and sharing of the antigen-measurement tools.

Topics